Related Experiment Video
Updated: Mar 27, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
The obese patient: a problem of larger consequence
1200 1st Street Rochester, Minnesota, 55905, USA.
The Bone & Joint Journal
|January 7, 2016
Summary
Obesity presents challenges in joint arthroplasty, including increased surgical complications. However, obese patients achieve good long-term outcomes and high satisfaction, suggesting weight alone should not preclude surgery.
Area of Science:
- Orthopedic Surgery
- Obesity Medicine
- Public Health
Background:
- Obesity is a global epidemic with significant economic and health impacts.
- Obese patients undergoing hip and knee arthroplasty face increased peri-operative risks and technical challenges.
- Despite risks, outcomes for obese patients in joint replacement surgery warrant further investigation.
Purpose of the Study:
- To evaluate the clinical outcomes and implant survival rates in obese patients following hip and knee arthroplasty.
- To determine if patient weight should be a sole contraindication for joint replacement surgery.
Main Methods:
- Review of peri-operative complications in obese patients undergoing hip and knee arthroplasty.
- Analysis of long-term clinical outcomes and implant survival rates.
- Comparison of patient satisfaction levels between obese and non-obese cohorts.
Main Results:
- Obese patients experienced earlier osteoarthritis symptoms, more medical problems, higher infection rates, and intra-operative difficulties.
- Despite challenges, long-term clinical outcomes and implant survival rates were favorable.
- Obese patients reported high satisfaction levels post-arthroplasty.
Conclusions:
- Obese patients demonstrate good long-term outcomes and implant survival after hip and knee arthroplasty.
- Weight should not be the sole reason to deny obese patients joint replacement surgery.
- Careful patient selection and management can optimize results for obese individuals.
Related Concept Videos
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
335
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
335
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
379
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
379
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
281
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
281
Stress Prevention and Stress Management Techniques IV
318
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
318
Binge Eating Disorders
741
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
741

